Aptinyx Total Liabilities 2011-2026 | APTX

Annual Total Liabilities Aptinyx

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
28.4 M	20.2 M	4.7 M	5.17 M	6.3 M	137 M	27.2 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
137 M	4.7 M	32.7 M

Quarterly Total Liabilities Aptinyx

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29.7 M	28.4 M	27.4 M	-	29.2 M	20.2 M	20.6 M	3.41 M	3.95 M	4.7 M	4.7 M	4.7 M	4.7 M	5.17 M	5.17 M	5.17 M	5.17 M	6.3 M	6.3 M	6.3 M	6.3 M	4.65 M	4.65 M	4.65 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
29.7 M	3.41 M	10.5 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Assembly Biosciences ASMB	50.8 M	$ 28.46	3.45 %	$ 319 M	USA
Ascendis Pharma A/S ASND	1.47 B	$ 221.88	-0.87 %	$ 5 B	Danmark
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Axsome Therapeutics AXSM	602 M	$ 156.92	-1.23 %	$ 7.81 B	USA
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
Pharming Group N.V. PHAR	191 M	$ 15.36	-0.71 %	$ 7.59 B	Niderland
Autolus Therapeutics plc AUTL	355 M	$ 1.37	-4.2 %	$ 350 M	Britain
Kamada Ltd. KMDA	32 M	$ 8.5	-1.39 %	$ 260 M	Israel
I-Mab IMAB	707 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Benitec Biopharma BNTC	2.3 M	$ 10.98	-4.52 %	$ 452 M	USA
Inventiva S.A. IVA	226 M	$ 5.78	-4.3 %	$ 138 M	France
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Compugen Ltd. CGEN	18.5 M	$ 2.09	-0.95 %	$ 195 M	Israel
Tiziana Life Sciences PLC TLSA	7.35 M	$ 1.21	-3.97 %	$ 71.5 M	Britain
ARCA biopharma ABIO	13.8 M	-	1052.0 %	$ 415 M	USA
Midatech Pharma plc MTP	6.46 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Aeterna Zentaris AEZS	21.9 M	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
PainReform Ltd. PRFX	2.7 M	$ 2.28	-0.44 %	$ 1.03 M	Israel
Acorda Therapeutics ACOR	395 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	5.38 M	-	4.01 %	$ 150 M	Canada
Foghorn Therapeutics FHTX	307 M	$ 5.0	2.25 %	$ 315 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Adverum Biotechnologies ADVM	109 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	28.4 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
AbCellera Biologics ABCL	390 M	$ 3.4	-3.68 %	$ 1.02 B	Canada
BioMarin Pharmaceutical BMRN	1.51 B	$ 54.13	-1.64 %	$ 10.4 B	USA
Curis CRIS	47.3 M	$ 0.77	1.89 %	$ 4.86 M	USA
Bellerophon Therapeutics BLPH	5.4 M	-	-74.18 %	$ 955 K	USA
AgeX Therapeutics AGE	6.61 M	-	-10.17 %	$ 12.2 K	USA
Coherus BioSciences CHRS	197 M	$ 1.52	-5.59 %	$ 178 M	USA
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany
Burford Capital Limited BUR	1.45 B	$ 7.7	-5.87 %	$ 1.29 B	Britain
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Cellectis S.A. CLLS	249 M	$ 3.34	-4.02 %	$ 116 M	France
Arbutus Biopharma Corporation ABUS	38.4 M	$ 4.24	-2.97 %	$ 704 M	Canada
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA
AIkido Pharma AIKI	7.27 M	-	1.93 %	$ 17.4 M	USA
Cardiff Oncology CRDF	16.5 M	$ 1.8	-1.1 %	$ 120 M	USA
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Cabaletta Bio CABA	17.5 M	$ 2.94	-3.29 %	$ 3.43 M	USA
Iterum Therapeutics ITRM	48.7 M	$ 0.16	-5.45 %	$ 3.15 M	Irlanda
Brickell Biotech BBI	6.5 M	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	15.9 M	-	3.16 %	$ 1.9 M	USA